Sunday, December 07, 2025 | 08:27 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Ajanta Pharma secures final approval for 3 ANDAs

Image

Capital Market

From USFDA

Ajanta Pharma has received final approval for its 3 ANDAs (Abbreviated New Drug Application) by US FDA (United States Food and Drug Administration) -

Montelukast Tablets, 10mg
Montelukast Sodium Chewable Tablets, 4mg & 5mg and
Montelukast oral granules.

Powered by Capital Market - Live News

 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 04 2015 | 10:19 AM IST

Explore News